📰 Genome Aggregation Database News
Page 2 - Genome Aggregation Database News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genome Aggregation Database. Real-time updates on events, politics, business and more.
July 6, 2022
Researchers have developed a method that uses big data to scan thousands of DNA samples and find cancerous mutations in cells.
July 5, 2022
Artificial intelligence and machine learning are among the latest tools being used by cancer researchers to aid in detection and treatment of the disease.
January 24, 2022
INDIANAPOLIS—A large data analysis led by Indiana University School of Medicine Professor Benjamin Gaston, MD, shows a rare respiratory disease called
December 22, 2021
Hearing loss is a common sensory deficit in humans with intricate genomic landscape and mutational signature. Approximately 1 - 3 out of 1,000 newborns have hearing loss and up to 60% of these cases have a genetic etiology. In this study, we conducted the concurrent newborn hearing and genetic screening in 20 mutations in GJB2, GJB3, SLC26A4 and MT-RNR1 for 9,506 normal newborns (4,977 [52.4%] males) from 22 ethnic population in South China. A total of 1,079 (11.4%) newborns failed to pass the i...
October 20, 2021
An international team of researchers, led by scientists at University of California San Diego and Shiley Eye Institute at UC San Diego Health, has broadened and deepened understanding of how inherited retinal dystrophies (IRDs) affect different populations of people and, in the process, have identified new gene variants that may cause the diseases.
October 14, 2021
/PRNewswire/ -- Cyprium Therapeutics, Inc. ("Cyprium"), a Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress") partner company, with support from its licensing...
October 9, 2021
Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper Histidinate, Presented at 2021 American Academy of Pediatrics National Conference & Exhibition - read this article along with other careers information, tips and advice on BioSpace
July 6, 2021
Study explores how human ACE2 variants can modify SARS-CoV-2 binding A recent tour-de-force study by researchers from the United Kingdom reveals variants of the human angiotensin-converting enzyme 2 (ACE2) that can improve or decrease binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – including two variants with distinct population distributions showing an enhanced affinity for viral spike glycoprotein. This research paper is currently available on the bioRxiv* pre...
June 1, 2021
Amazon Web Services doubles down on genomics Neil Versel, Genomeweb Getty Images Amazon Web Services has been expanding its reach into genomics and continues to grow in areas like molecular diagnostics through new initiatives. As might be expected of one of the worlds three largest commercial cloud platforms, AWS counts some well-known names in the genomics and bioinformatics world among its customers. "Over the past 15 years, AWS has helped remove the undifferentiated heavy lifting so that cus...
April 1, 2021
Our six dermatology products are marketed by our partner company, Journey Medical Corporation (“Journey”). Our products generated net revenues of $44.5 million for full-year 2020, compared to full-year 2019 net revenues of $34.9 million, representing growth of 28%. Our products generated $13.7 million in revenues in the fourth quarter of 2020, compared to $11.1 million in the fourth quarter of 2019, representing growth of 23%. While we generated revenue growth year-over-year in 2020, sales ...